71.
    发明专利
    未知

    公开(公告)号:AT552782T

    公开(公告)日:2012-04-15

    申请号:AT05770290

    申请日:2005-08-11

    Abstract: Intravascular ultrasound techniques provide for intravascular imaging using contrast agents and nonlinear techniques. An ultrasound imaging device for detecting internal properties of a target body comprises an ultrasound transducer positioned at a distal end portion of a catheter, for transmitting excitation pulses and for receiving echo signals. A signal processor analyses echo signals at harmonics and/or subharmonics of the transmit frequency. The catheter may include a contrast agent delivery conduit extending along the catheter, the delivery conduit having an exit orifice proximal to the ultrasound transducer. The device may discriminate between echo signals respectively arising from interaction with tissue and from the interaction with contrast agent. The device may generate an image of the site of interest using non-linear components of the received ultrasound echo signals.

    RARE-EARTH IODIDE SCINTILLATION CRYSTALS

    公开(公告)号:IL172125A

    公开(公告)日:2010-04-29

    申请号:IL17212505

    申请日:2005-11-23

    Abstract: The invention relates to an inorganic rare-earth iodide scintillation material of formula A X Ln (y-y',) Ln' y' I (x+3y) in which: A represents at least one element selected among Li, Na, K, Rb, Cs; Ln represents at least one first rare-earth element selected among La, Gd, Y, Lu, said first rare-earth element having a valency of 3+ in the aforementioned formula: Ln' represents at least one second rare-earth element selected among Ce, Tb, Pr, said second rare-earth element having a valency of 3+ in the aforementioned formula, x is an integer and represents 0, 1, 2 or 3; y is an integer or non-integer greater than 0 and less than 3, and; y' is an integer or non-integer greater than 0 and less than y. This material presents a high stopping power, a rapid decay time, in particular, less than 100 ns, a good energy resolution (in particular, less than 6% at 662 keV) and a high luminous level. This material can be used in nuclear medicine equipment, in particular, in Anger-type gamma cameras and in positron emission tomography scanners.

    HOMOGENEOUS, INTRINSIC RADIOPAQUE EMBOLIC PARTICLES

    公开(公告)号:IL198458D0

    公开(公告)日:2010-02-17

    申请号:IL19845809

    申请日:2009-04-30

    Abstract: The invention is directed to embolic material comprising spherical, homogeneous and substantially non-porous radiopaque polymer particles based on at least one hydrophilic monomer and at least one radiopaque monomer according to general formula wherein R is H, methyl or ethyl, and R1 is I, Br or wherein R2 is O, NH, O-[CH2-CH2-O]p-C(O)-, O-[CH2]m-O-C(O)-, O-[CH2]p-, NH-[CH2-CH2-O]p-C(O)-, NH-[CH2]m-O-C(O)- or NH-[CH2]p- wherein m>1 and p>=1, R3 is I or Br and n is 1, 2 or 3, the iodine and/or bromine content being at least 5 wt. % based on the dry weight of the particle, the said particles having an average particle diameter of at least 10 mum and being able to imbibe water up to a volume increase of the particle of at least 10%.

    80.
    发明专利
    未知

    公开(公告)号:AT454146T

    公开(公告)日:2010-01-15

    申请号:AT07808509

    申请日:2007-08-29

    Abstract: The present invention relates to a pharmaceutical composition for photodynamic treatment of a fungal skin disorder, said pharmaceutical composition comprising a photosensitizer and an enhancer, wherein the photosensitizer is a cationic photosensitizer and the enhancer is chosen from the group of i) an acid, and ii) a metal chelating agent. Such a composition is capable of eliminating both conidiae and hy-phae. The invention also relates to a method for the preparation of the pharmaceutical composition.

Patent Agency Ranking